Evidence map›Paper›PMID 36563168›Full record

ArticleScience immunology2022

Neutrophils and macrophages drive TNF-induced lethality via TRIF/CD14-mediated responses.

Hayley I Muendlein, Wilson M Connolly, James Cameron, David Jetton, Zoie Magri, Irina Smirnova, Edouard Vannier, Xudong Li, Amanda J Martinot, Rebecca Batorsky and 1 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Inflammatory factors collaboratively linkFrontiers in immunology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hayley I MuendleinDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.ORCID 0000-0003-3006-5780
Wilson M ConnollyDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
James CameronGraduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.
David JettonGraduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.ORCID 0000-0002-1615-9986
Zoie MagriGraduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.ORCID 0000-0001-9378-4278
Irina SmirnovaDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Edouard VannierDivision of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA 02111, USA.ORCID 0000-0001-6654-9053
Xudong LiDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Amanda J MartinotDepartment of Infectious Diseases and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA.ORCID 0000-0001-6237-6191
Rebecca BatorskyData Intensive Studies Center, Tufts University, Medford, MA 02155, USA.
Alexander PoltorakDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.ORCID 0000-0002-5375-6587
Tufts University · USTufts Medical Center · US

Funding

Hyper-Responsiveness to TLR Agonists in Wild Derived MiceR01AI056234 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2003 to 2023
$8.4M
Regulation of LPS-responses by ZBP1R01AI167245 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2021 to 2025
$3.6M
DNA-RESPONSES IN WILD-DERIVED MICER21AI135369 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2018 to 2019
$454k
Hyper-Responsiveness to TLR Agonists in Wild Derived MiceR56AI056234 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2008 to 2008
$411k
NIAID NIH HHS R01 AI056234NIAID NIH HHS R01 AI167245NIAID NIH HHS R21 AI135369NIAID NIH HHS R56 AI056234
6 · The paper itself

Abstract

TNF mediates a variety of biological processes including cellular proliferation, inflammatory responses, and cell death and is therefore associated with numerous pathologies including autoinflammatory diseases and septic shock. The inflammatory and cell death responses to TNF have been studied extensively downstream of TNF-R1 and are believed to rely on the formation of proinflammatory complex I and prodeath complex II, respectively. We recently identified a similar multimeric complex downstream of TLR4, termed the TRIFosome, that regulates inflammation and cell death in response to LPS or

Indexed as

NeutrophilsReceptors, Tumor Necrosis Factor, Type IAdaptor Proteins, Vesicular TransportAnimalsInflammationLipopolysaccharide ReceptorsLipopolysaccharidesMacrophagesMiceSignal TransductionToll-Like Receptor 4Tumor Necrosis FactorsAdaptor Proteins, Vesicular TransportCd14 protein, mouseLipopolysaccharide ReceptorsLipopolysaccharidesReceptors, Tumor Necrosis Factor, Type IToll-Like Receptor 4Tumor Necrosis Factors

Identifiers

PMID36563168
PMCPMC10021564
OpenAlexW4312109335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.